金城医药：公司子公司金城泰尔生产和销售磷酸奥司他韦原料药

Core Viewpoint - Jincheng Pharmaceutical (300233) announced on November 13 that its subsidiary, Jincheng Taier, produces and sells Oseltamivir phosphate raw materials, which are used for the treatment and prevention of H1N1 influenza [1] Group 1 - The company is involved in the production and sales of Oseltamivir phosphate, a key antiviral medication [1] - The end formulation products of Oseltamivir phosphate are specifically indicated for the treatment and prevention of H1N1 influenza [1]